Company: VCYT
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001384101-25-000110
Chunk: 80

Company: VERACYTE, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 80
---
 federal court in the Eastern District of Texas alleging that Sonic Healthcare USA, Inc., the healthcare company that is believed to offer ThyroSeq v3, is infringing three of the Company’s patents related to molecular testing of thyroid nodules. The complaint seeks treble damages, attorneys’ fees and costs as well as injunctive relief. On June 4, 2025, the Company filed an amended complaint asserting two additional patents. On July 21, 2025, Sonic Healthcare USA, Inc. filed an answer and a motion to dismiss. The jury trial is currently scheduled for January 25, 2027.

7. Stockholders’ Equity

 Common Stock The Company had reserved shares of common stock for issuance as follows:  June 30, 2025December 31, 2024Stock options and restricted stock units issued and outstanding5,691,373 5,773,382 Stock options and restricted stock units available for grant under stock option plans10,742,036 8,971,566 Common stock available for the Employee Stock Purchase Plan966,979 1,051,407 Total17,400,388 15,796,355 

16

8. Components of Other Income

Other income, net consists of the following (in thousands of dollars): Three Months Ended June 30,Six Months Ended June 30, 2025202420252024Interest income2,937 2,699 5,699 5,394 Interest expense— (1)(1)(1)Gain (loss) on currency revaluation3,348 (171)4,895 (731)Other233 228 449 841  Total$6,518 $2,755 $11,042 $5,503 

9. Segment

The chief operating decision maker for the Company is the Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of allocating resources and assessing financial performance.  The Company has a single reporting unit associated with the development and commercialization of diagnostic products and biopharmaceutical services. The accounting policies of the Company's single segment are the same as those described in the summary of significant accounting policies in Note 1, Organization, Description of Business and Summary of Significant Accounting Policies. The chief operating decision maker assesses performance of the Company's single segment and decides how to allocate resources based on consolidated net income. Under the current organizational structure, this measure is not discreet